Q&A
AbSeS (Abdominal Sepsis Study: Epidemiology of Etiology and Outcome) is a multinational, prospective, observational study on intra-abdominal infections (IAIs) in critically ill patients with a special emphasis on epidemiology and outcomes.
The specific objectives of this study are:
Data collection began on 1st January and has been completed on 31 December 2016.
K. Arvaniti, G. Dimopoulos, M. Antonelli et al., Epidemiology and age-related mortality in critically ill patients with intra-abdominal infection or sepsis: an international cohort study, International Journal of Antimicrobial Agents; article in press on May 21, 2022: https://doi.org/10.1016/j.ijantimicag.2022.106591.
Dirk Vogelaers, Stijn Blot, Andries Van den Berge, Philippe Montravers, Abdominal Sepsis Study (‘AbSeS’) Group on behalf of the Trials Group of the Europan Society f Intensive Care Medicine Antimircrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units Drugs, 2021 Jun;81(9):1065-1078. doi: 10.1007/s40265-021-01534-w. Epub 2021 May 26.
The primary paper: Blot S, Antonelli M, Arvaniti K, Blot K, Creagh-Brown B, de Lange D, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project. Intensive Care Medicine volume 45, pages 1703–1717 (2019) – PubMed – PMC
For more information, please contact research@esicm.org